Cargando…

Risk impact of edoxaban in the management of stroke and venous thromboembolism

The new generation of target-specific oral anticoagulants is being prescribed for increasing numbers of patients at risk of stroke or venous thromboembolism (VTE). These drugs offer valuable benefits due to fast onset anticoagulation, a fixed anticoagulation effect (allowing administration of specif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurst, Katherine V, O’Callaghan, John Matthew, Handa, Ashok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986674/ https://www.ncbi.nlm.nih.gov/pubmed/27563246 http://dx.doi.org/10.2147/VHRM.S94679

Ejemplares similares

Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism
por: Tellor, Katie B, et al.
Publicado: (2016)

Edoxaban in venous thromboembolism and stroke prevention: an appraisal
por: Proietti, Marco, et al.
Publicado: (2016)

Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism
por: Said, Karim
Publicado: (2013)

Genetics and clinical response to warfarin and edoxaban in patients with venous thromboembolism
por: Vandell, Alexander G, et al.
Publicado: (2017)

Quick reference guide to apixaban
por: Hurst, Katherine Victoria, et al.
Publicado: (2017)

The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease
por: van Ommen, Cornelia Heleen, et al.
Publicado: (2020)

Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism
por: Stacy, Zachary A., et al.
Publicado: (2016)

Educating surgical patients to reduce the risk of venous thromboembolism: an audit of an effective strategy
por: Sadideen, Hazim, et al.
Publicado: (2011)

Assessment of the Safety and Efficacy of Edoxaban for the Treatment of Venous Thromboembolism Secondary to Active Malignancy
por: Hara, Nobuhiro, et al.
Publicado: (2017)

Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
por: Medina, Andria, et al.
Publicado: (2017)

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
por: Clay, Emilie, et al.
Publicado: (2018)

Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?
por: Camporese, Giuseppe, et al.
Publicado: (2020)

Edoxaban for Venous Thromboembolism Treatment—The New Kid on The Block for Latin America. A Practical Guide
por: Ramacciotti, Eduardo, et al.
Publicado: (2018)

Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide
por: De Caterina, Raffaele, et al.
Publicado: (2017)

Efficacy and Safety of Edoxaban in Cancer-Associated Venous Thromboembolism: A Real World Retrospective Study
por: Grifoni, Elisa, et al.
Publicado: (2022)

Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data
por: Odajima, Suguru, et al.
Publicado: (2022)

A Case of Tuberculosis-related Cerebral Venous Sinus Thrombosis and Pulmonary Thromboembolism Successfully Treated with Edoxaban
por: Nishino, Koichi, et al.
Publicado: (2022)

Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report
por: Nakao, Satoshi, et al.
Publicado: (2019)

Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
por: Fuji, Takeshi, et al.
Publicado: (2015)

Edoxaban treatment for pulmonary arterial thromboembolism associated with azygous vein aneurysm
por: Mochimaru, Takao, et al.
Publicado: (2017)

Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage
por: Shoji, Tetsuaki, et al.
Publicado: (2018)

Update on Edoxaban for the Prevention and Treatment of Thromboembolism: Clinical Applications Based on Current Evidence
por: Zalpour, Ali, et al.
Publicado: (2015)

The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for Management
por: George, Anil P., et al.
Publicado: (2019)

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study
por: Scheres, LJJ, et al.
Publicado: (2018)

Managing patients taking edoxaban in dentistry
por: Curto, Adrian, et al.
Publicado: (2017)

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study
por: Rinde, Ludvig B., et al.
Publicado: (2016)

Management of venous thromboembolism: an update
por: Piran, Siavash, et al.
Publicado: (2016)

Venous thromboembolism: current management
por: Stevens, Hannah, et al.
Publicado: (2019)

Venous Thromboembolism: Classification, Risk Factors, Diagnosis, and Management
por: Moheimani, Fatemeh, et al.
Publicado: (2011)

Risk and Management of Venous Thromboembolism in Patients with COVID-19
por: Skeik, Nedaa, et al.
Publicado: (2021)

Venous ligation versus venous repair: does the procedure impact venous thromboembolism risk?
por: Farrell, Michael Steven, et al.
Publicado: (2021)

Treatment of pulmonary thromboembolism with edoxaban in a cancer patient with borderline fulfillment of the dose reduction criteria
por: Takama, Takuro, et al.
Publicado: (2019)

Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis
por: Cohen, A. T., et al.
Publicado: (2015)

Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
por: Cohen, Alexander T., et al.
Publicado: (2018)

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation
por: Sokol, Juraj, et al.
Publicado: (2020)

Venous thromboembolism and cancer risk
por: Sandén, Per, et al.
Publicado: (2016)

Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
por: Tøndel, Birgitte G., et al.
Publicado: (2022)

The Impact of Central Venous Catheters on Pediatric Venous Thromboembolism
por: Jaffray, Julie, et al.
Publicado: (2017)

Recent advances in the management of venous thromboembolism
por: Ageno, Walter
Publicado: (2010)

Thrombotic Risk in Cancer Patients: Diagnosis and Management of Venous Thromboembolism
por: Citro, Rodolfo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q998rkkdpktnlbrjdmfro7qaba